SUBSTITUTED AMIDES, METHOD OF DECREASE OF TUMOR NECROSIS FACTOR (TNF) LEVEL AND INHIBITION OF PHOSPHODIESTERASE ACTIVITY AND PHARMACEUTICAL COMPOSITION Russian patent published in 2003 - IPC

Abstract RU 2196134 C2

FIELD: organic chemistry, biochemistry. SUBSTANCE: invention describes novel substituted imides of the general formula (I) where Y means or ; m = 0-3; R5 means: unsubstituted o-phenylene or o-phenylene substituted with one or more substitutes each of that is taken independently from nitro-group, C1-4-alkyl, amine, carbamoyl substituted with C1-3-alkyl, acetoxy-, carboxy-, hydroxy-, amino-group substituted with C1-3-alkyl or bivalent residue of pyridine, pyrrolidine, imidazole, naphthalene or thiophene; R6 means -CO-, -CH2-, -CH2CO-, SO2; R7 means phenyl substituted with two substitutes taken independently among unbranched or cyclic C1-C10-alkoxy-group; n = 0, 1, 2 or 3. Invention relates also to method of decrease of levels of tumor necrosis α-factor, method of inhibition of activity of phosphodiesterase and to pharmaceutical composition. These compounds are inhibitors of tumor necrosis α-factor and phosphodiesterase and can be used for control against cachexia, endotoxic shock, replication of retroviruses, asthma and inflammatory states. EFFECT: improved method of decrease of tumor necrosis factor levels and inhibition of phosphodiesterase activity. 5 cl

Similar patents RU2196134C2

Title Year Author Number
2,6-DIOXOPIPERIDINE, METHOD FOR REDUCTION OF UNDESIRABLE LEVELS OF TNF-ALPHA IN MAMMAL, PHARMACEUTICAL COMPOSITION 1998
  • Maller Dzhordzh U.
  • Sterling Dejvid I.
  • Chen Rodzher Shen-Chu
RU2209207C2
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TNF LEVEL, METHOD OF INHIBITION OF TNF-ACTIVATED REPLICATION OF RETROVIRUSES AND PHARMACEUTICAL COMPOSITION 1995
  • Dzhordzh Mjuller
  • Meri Shir
  • Dehvid I. Stirling
RU2162078C2
IMMUNOTHERAPEUTIC IMIDES/AMIDES AS INHIBITORS OF PHOSPHODI-ESTERASE-IV (PDE-IV) AND TUMOR NECROSIS FACTOR (TNF) 1997
  • Maller Dzhordzh U.
  • Shajr Mehri
  • Sterling Dejvid I.
RU2177471C2
SUCCINIMIDE AND MALEIMIDE INHIBITORS OF CYTOKINS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF TUMOR NECROSIS α-FACTOR 1996
  • Dzhordzh V. Mjuller
  • Mehri Shajr
RU2176242C2
IMIDE/AMIDE ETHERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF FNOK LEVEL IN MAMMALIAN 1995
  • Dzhordzh Mjuller
  • Mehri Shir
  • Dehvid I. Stirling
RU2164514C2
NOVEL IMMUNOTHERAPEUTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF DECREASE OF LEVELS OF PHDE, TNF ALPHA AND NFKB 1997
  • Maller Dzhordzh U.
  • Shajr Mehri
RU2188819C2
IMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE, α, ФHO 1996
  • Maller Dzhordzh V.
  • Shajr Mehri
RU2174512C2
SUBSTITUTED HYDROXAMIC ACIDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD OF TNF (TUMOR NECROSIS FACTOR) α DECREASE 1998
  • Maller Dzhordzh V.
  • Man Khon-Vo
RU2199530C2
ARYLAMIDES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF TNF-ACTIVATED RETROVIRUS REPLICATION 1995
  • Dzhordzh Mjuller
  • Mehri Shir
  • Dehvid I. Stirling
RU2162839C2
DERIVATIVES OF 2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE, THEIR SYNTHESIS AND APPLICATION AS INHIBITORS OF INFLAMMATORY CYTOKINES 1999
  • Mehn Khon-Va
  • Maller Dzhordzh U.
RU2200159C2

RU 2 196 134 C2

Authors

Mjuller Dzhordzh V.

Shajr Mehri

Dates

2003-01-10Published

1996-08-29Filed